Despina Yancopoulou

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano et al. · Clinical Immunology · 2020 · 287 citations · Full text

Complement System, Covid-19 Pandemic, Immunology +7

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca et al. · Clinical Immunology · 2020 · 256 citations · Full text

Complement System, Differential Biological Efficacy, Covid-19 Pandemic +8

Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing

Despina Yancopoulou, Peter J. Nestor, John H. Xuereb et al. · Brain · 2005 · 131 citations

Selective Verb Deficit, Neuropsychology, Corticobasal Degeneration +19

Chromosome 3 linked frontotemporal dementia (FTD-3)

Susanne Gydesen, J. Morgan Brown, A. Brun et al. · Neurology · 2002 · 111 citations

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos et al. · Science Advances · 2022 · 51 citations · Full text